Eli Lilly Stock Up 21% in 6 Months: Time to Add to Your Portfolio?

Eli Lilly and Company’s (LLY) stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The stock has also outperformed the sector as well as the S&P 500 as seen in the chart below.LLY Stock Outperforms Industry, Sector & S&P 500    Image Source: Zacks Investment ResearchLilly has seen unparalleled success with its GLP-1 drugs, Mounjaro and Zepbound. In the past couple of years, it has received approvals for several new drugs like Kisunla, Omvoh and Jaypirca and witnessed pipe ...